A Marathon for ALS
Everyone can make a difference: through a gesture, a word, or by sharing a project.
Giovanni-Battista (Bacci) and Giacomo believe in this! That’s why they are launching a fundraising campaign ―'A Marathon for ALS'―to support scientific research on Amyotrophic Lateral Sclerosis (ALS), a disease that Bacci has been fighting for some time.
Together with Giacomo, who will run the New York Marathon in November 2025, they are sending a powerful message of trust and hope for scientific research, inviting everyone to join this inspiring initiative.
The donations will fund two ALS research projects. The first project is‘FLYGEN’, coordinated by Dr. Arianna Manini from the Italian Auxological Institute in Milan, which aims to identify new genetic causes of ALS using an innovative technique capable of detecting structural variations in the genome that are missed by more common technologies.The second project is ‘Seed-NMR’, coordinated by Dr. Linda Cerofolini of the University of Florence, which aims to develop new analytical methods, using nuclear magnetic resonance, to support early diagnosis and personalised treatment of patients with ALS.
Bacci and Giacomo sincerely thank you for your support!
Everyone can make a difference: through a gesture, a word, or by sharing a project.
Giovanni-Battista (Bacci) and Giacomo believe in this! That’s why they are launching a fundraising campaign ―'A Marathon for ALS'―to support scientific research on Amyotrophic Lateral Sclerosis (ALS), a disease that Bacci has been fighting for some time.
Together with Giacomo, who will run the New York Marathon in November 2025, they are sending a powerful message of trust and hope for scientific research, inviting everyone to join this inspiring initiative.
The donations will fund two ALS research projects. The first project is‘FLYGEN’, coordinated by Dr. Arianna Manini from the Italian Auxological Institute in Milan, which aims to identify new genetic causes of ALS using an innovative technique capable of detecting structural variations in the genome that are missed by more common technologies.The second project is ‘Seed-NMR’, coordinated by Dr. Linda Cerofolini of the University of Florence, which aims to develop new analytical methods, using nuclear magnetic resonance, to support early diagnosis and personalised treatment of patients with ALS.
Bacci and Giacomo sincerely thank you for your support!